Omeprazole

Half-Life (t½)
PO: 36m · IV: 36m
Formula
C17H19N3O3S
Molecular Weight
345.42 g/mol
PubChem CID
4594
Aliases
Prilosec

Pharmacological Mechanism

Irreversible H+/K+-ATPase inhibitor — covalently binds activated proton pumps in gastric parietal cells. CYP2C19 substrate (poor metabolizers have 5× higher AUC); also moderate CYP2C19 inhibitor (lowers clopidogrel activation).

Half-Life & Elimination Curve (PO: 36m · IV: 36m)

100%50%25%12.5%0%0h0×t½36m1×t½1.2h2×t½1.8h3×t½2.4h4×t½3h5×t½0×t½ (0h): 100% remaining (~0.503 mg/L)1×t½ (36m): 50% remaining (~0.252 mg/L)2×t½ (1.2h): 25% remaining (~0.126 mg/L)3×t½ (1.8h): 12.5% remaining (~62.9 µg/L)4×t½ (2.4h): 6.3% remaining (~31.5 µg/L)5×t½ (3h): 3.1% remaining (~15.7 µg/L)
Plasma (PO)t½ Decay (36m)
  • 0×t½0h100% (0.503 mg/L)
  • 1×t½36m50% (0.252 mg/L)
  • 2×t½1.2h25% (0.126 mg/L)
  • 3×t½1.8h12.5% (62.9 µg/L)
  • 4×t½2.4h6.3% (31.5 µg/L)
  • 5×t½3h3.1% (15.7 µg/L)
Elimination t½36m (PO)
Rate Constant (ke)1.16 h⁻¹
Time to Peak (Tmax)26m
Est. Peak (Cmax)0.503 mg/L
Clearance (CL)13.9 L/h
97% Washout (5×t½)3h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References